Dynamics of component exchange at PML nuclear bodies

Journal of Cell Science

Volumn 121, Issue 16, 2008, Pages 2731-2743

  Weidtkamp Peters, Stefanie ^a   Lenser, Thorsten ^b   Negorev, Dmitri ^c   Gerstner, Norman ^a   Hofmann, Thomas G ^d   Schwanitz, Georg ^a   Hoischen, Christian ^a   Maul, Gerd ^c   Dittrich, Peter ^b   Hemmerich, Peter ^a  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c WISTAR INSTITUTE   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Assembly; FCS; FRAP; Kineticss modeling; Nuclear body; Promyelocytic leukemia; RAR ; SP100; SUMO

Indexed keywords

ADENOSINE TRIPHOSPHATE; BLOOM SYNDROME HELICASE; DAXX PROTEIN; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; NUCLEAR PROTEIN; PHOSPHOTRANSFERASE; PROMYELOCYTIC LEUKEMIA PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN IV; PROTEIN SP100; RETINOIC ACID RECEPTOR ALPHA; SUMO PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; DYNAMICS; EMBRYO; HUMAN; HUMAN CELL; KINETICS; LEUKEMIA CELL; MATHEMATICAL MODEL; MOLECULAR IMAGING; ONCOGENE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; SUMOYLATION; TEMPERATURE; WILD TYPE;

ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL NUCLEUS; CELLS, CULTURED; DIFFUSION; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; INTRANUCLEAR INCLUSION BODIES; KINETICS; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SUBSTRATE SPECIFICITY; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 52649120917     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.031922     Document Type: Article

References (84)

1. Ascoli, C. A. and Maul, G. G. (1991). Identification of a novel nuclear domain. J. Cell Biol. 112, 785-795.
2. Banks, D. S. and Fradlin, C. (2005). Anomalous diffusion of proteins due to molecular crowding. Biophys. J. 89, 2960-2971.
3. Bernardi, R. and Pandolfi, P. P. (2007). Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell. Biol. 8, 1006-1016.
4. Doe, S. O., Haave, M., Jul-Larsen, A., Grudic, A., Bjerkvig, R. and Lonning, P. E. (2006). Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA. J. Cell Sci. 119, 3284-3295.
5. Boisvert, F. M., Hendzel, M. J. and Bazett-Jones, D. P. (2000). Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148, 282-292.
6. Boisvert, F. M., Kruhlak, M. J., Box, A. K., Hendzel, M. J. and Razett-Jones, D. P. (2001). The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J. Cell Biol. 152, 1099-1106.
7. Borden, K. L. (2002). Pondering the promyclocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell. Biol. 22, 5259-5269.
8. Carbone, R., Pearson, M., Minucci, S. and Pelicci, P. G. (2002). PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage. Oncogene 21, 1633-1640.
9. Chen, D. and Huang, S. (2001). Nucleolar components involved in ribosome biogenesis cycle between the nucleolus and nucleoplasm in interphase cells. J. Cell Biol. 153, 169-176.
10. Condemine, W., Takahashi, Y., Zhu, J., Puvion-Dutillieul, F., Guegan, S., Janin, A. and de The, H. (2006). Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res. 66, 6192-6198.
11. Condemine, W., Takahashi, Y., Le Bras, M. and de Thé, H. (2007). A nucleolar targeting signal in PML-1 addresses PML to nucleolar caps in stressed or senescent cells. J. Cell Sci. 120, 3219-3227.
12. D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Coen, S., Marchetti, A., Del Sal G. et al. (2002). Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 4, 11-19.
13. Daniel, M. T., Koken, M., Romagni, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M. C., Degos, L., Chomienne, C. and de Thé, H. (1993). PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82, 1858-1867.
14. Dellaire, G. and Bazett-Jones, D. P. (2004). PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26, 963-977.
15. Dellaire, G., Eskiw, C. H., Dehghani, H., Ching, R. W. and Bazett-Jones, D. P. (2006). Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1. J. Cell Sci. 119, 1034-1042.
16. de Thé H., Chomienne, C., Lanotte, M., Degos, L. and Dejean, A. (1990). The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347, 558-561.
17. Dong, S., Stenoien, D. L., Qiu, J., Mancini, M. A. and Tweardy, D. J. (2004). Reduced intranuclear mobility of APL fusion proteins accompanies their mislocalization and results in sequestration and decreased mobility of retinoid X receptor alpha. Mol. Cell. Biol. 24, 4465-4475.
18. Dundr, M., Hebert, M. D., Karpova, T. S., Stanek, D., Xu, H., Shpargel, K. B., Meier, U. T., Neugebauer, K. M., Matera, A. G. and Misteli, T. (2004). In vivo kinetics of Cajal body components. J. Cell Biol. 164, 831-842.
19. Dyck, J. A., Maul, G. G., Miller, Jr, W. H., Chen, J. D., Kakizuka, A. and Evans, R. M. (1994). A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76, 333-343.
20. Eskiw, C. H., Dellaire, G. and Bazett-Jones, D. P. (2004). Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SLTMO-1-independent mechanism. J. Biol. Chem. 279, 9577-9585.
21. Everett, R. D. (2006). Interactions between DNA viruses, ND10 and the DNA damage response. Cell. Microbiol. 8, 365-374.
22. Everett, R. D. and Murray, J. (2005). ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J. Virol. 79, 5078-5089.
23. Everett, R. D., Lomonte, P., Sternsdorf, T., van Driel, R. and Orr, A. (1999). Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112, 4581-4588.
24. Fogal, V., Gostissa, M., Sandy, P., Zacchi, P., Sternsdorf, T., Jensen, K., Pandolfi, P. P., Will, H., Schneider, C. and Del Sal, G. (2000). Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19, 6185-6195.
25. Gambacorta, M., Flenghi, L., Fagioli, M., Pileri, S., Leoncini, L., Bigerna, B., Pacini, R., Tanci, L. N., Pasqualucci, L., Ascani, S. et al. (1996). Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am. J. Pathol. 149, 2023-2035.
26. Goddard, A. D., Borrow, J., Freemont, P. S. and Solomon, E. (1991). Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254, 1371-1374.
27. Görisch, S. M., Wachsmuth, M., Ittrich, C., Bacher, C. P., Rippe, K. and Lichter, P. (2004). Nuclear body movement is determined by chromatin accessibility and dynamics. Proc. Natl. Acad. Sci. USA 101, 13221-13226.
28. Guo, A., Salomoni, P., Luo, J., Shih, A., Zhong, S., Gu, W. and Pandolfi, P. P. (2000). The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2, 730-736.
29. Handwerger, K. E., Murphy, C. and Gall, J. G. (2003). Steady-state dynamics of Cajal body components in the Xenopus germinal vesicle. J. Cell Biol. 160, 495-504.
30. Hansen, N. and Ostermeier, A. (2001). Completely derandomized self-adaptation in evolution strategies. Evolutionary Computation 9, 159-195.
31. Hemmerich, P. and Diekmann, S. (ed.) (2005). Visions of the Cell Nucleus. CA, USA: American Scientific Publishers.
32. Hemmerich, P., Weidtkamp-Peters, S., Hoischen, C., Schmiedeberg, L., Erliandri, I. and Diekmann, S. (2008). Dynamics of inner kinetochore assembly and maintenance in living cells. J. Cell Biol. 180, 1101-1114.
33. Hink, M. A., Griep, R. A., Borst, J. W., van Hoek, A., Eppink, M. H., Schots, A. and Visser, A. J. (2000). Structural dynamics of green fluorescent protein alone and fused with a single chain Fv protein. J. Biol. Chem. 275, 17556-17560.
34. Hofmann, T. G., Moller, A., Sirma, H., Zentgraf, H., Taya, Y., Droge, W., Will, H. and Schmitz, M. L. (2002). Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 4, 1-10.
35. Hofmann, T. G., Stollberg, N., Schmitz, M. L. and Will, H. (2003). HIPK2 regulates transforming growth factor-beta-induccd c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res. 63, 8271-8277.
36. Huang, Y., Qiu, J., Chen, G. and Dong, S. (2007). Coiled-coil domain of PML is essential for the aberrant dynamics of PML-RARalpha, resulting in sequestration and decreased mobility of SMRT. Biochem. Biophys. Res Cammun. 365, 258-265.
37. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T., Strauss, J. E. R. and Maul, G. G. (1999). PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147, 221-234.
38. Jensen, K., Shiels, C. and Freemont, P. S. (2001). PML protein isoforms and the RBCC/TRIM motif. Oncogene 20, 7223-7233.
39. Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T. and Yeh, E. T. (1998). Identification of three major sentrinization sites in PML. J. Biol. Chem. 273, 26675-26682.
40. Kentsis, A., Gordon, R. E. and Borden, K. L. (2002). Self-assembly properties of a model RING domain. Proc. Natl. Acad. Sci. USA 99, 667-672.
41. Kentsis, A. and Borden, K. L. (2004). Physical mechanisms and biological significance of supramolecular protein self-assembly. Curr. Protein Pept. Sci. 5, 125-134.
42. Kiesslich, A., von Mikecz, A. and Hemmerich, P. (2002). Cell cycle-dependent association of PML bodies with sites of active transcription in nuclei of mammalian cells. J. Struct. Biol. 140, 167-179.
43. Koken, M. H. M., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., Chomienne, C. et al. (1994). The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13, 1073-1079.
44. Kruhlak, M. J., Levert, M. A., Fischle, W., Verdin, E., Bazett-Jones, D. P. and Hendzel, M. J. (2000). The mobility of the GFP:ASF splicing factor in live cells. J. Cell Biol. 150:41-51.
45. Kumar, P. P., Bischof, O., Purbey, P. K., Notani, D., Urlaub, H., Dejean. A. and Galande, S. (2007). Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat. Cell Biol. 9, 45-56.
46. Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honore, N., Doubeikovsky, A., Duprez, E., Pandolfi, P. P., Puvion, E., Freemont, P. et al. (2001). Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As203-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193, 1361-1371.
47. Lamond, A. I. and Earnshaw, W. C. (1998). Structure and function in the nucleus. Science 280, 547-553.
48. Lanctôt, C., Cheutin, Z., Cremer, M., Cavalli, G. and Cremer, T. (2007). Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions. Nat. Rev. Genet. 8, 104-115.
49. Le X. F., Yang, P. and Chang, K. S. (1996). Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J. Biol. Chem. 271, 130-135.
50. Lin, D. Y., Huang, Y. S., Jeng, J. C., Kuo, H. Y., Chang, C. C., Chao, T. T., Ho, C. C., Chen, Y. C., Lin, T. P., Fang, H. I. et al. (2007). Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell. 24, 341-354.
51. Maul, G. G., Yu, E., Ishov, A. M. and Epstein, A. L. (1995). Nuclear domain 10 (ND10) associated proteins are also present in NBs and redistribute to hundreds of nuclear sites after stress. J. Cell. Biochem. 59, 498-513.
52. Maul, G. G., Negorev, D., Bell, P. and Isbov, A. M. (2000). Properties and assembly mechanisms of ND10, PML bodies, or PODs. J. Struct. Biol. 129, 278-287.
53. Melnick, A. and Licbt, J. D. (1999). Deconstructing a disease: RAR, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93, 3167-3215.
54. Misteli, T. (2008). Physiological importance of RNA and protein mobility in the cell nucleus Histochem. Cell Biol. 129, 5-11.
55. Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G. and Chang, K. S. (1994). PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14, 6858-6867.
56. Naka, K., Ikeda, K. and Motoyama, N. (2002). Recruitment of NBS1 into PML oncogenic domains via interaction with SP100 protein. Biochem. Biophys. Res. Commun. 299, 863-871.
57. Negorev, D. and Maul, G. G. (2001). Cellular proteins localized at and interacting within ND10/PML NBs/PODs suggest functions of a nuclear depot. Oncogene 20, 7234-7242.
58. Negorev, D., Ishov, A. M. and Maul, G. G. (2001). Evidence for separate ND10-binding and homo-oligomerization domains of Sp100. J. Cell Sci. 114, 59-68.
59. Phair, R. D. and Misteli, T. (2000). High mobility of proteins in the mammalian cell nucleus. Nature 404, 604-609.
60. Platani, M., Goldberg, I., Lamond, A. I. and Swedlow, J. R. (2002). Cajal Body dynamics and association with chromatin are ATP-dependent. Nat. Cell Biol. 4, 502-508.
61. Quimby, B. B., Yong-Gonzalez, V., Anan, T., Strunnikov, A. V. and Dasso, M. (2006). The promyelocytic leukemia protein stimulates SUMO conjugation in yeast. Oncogene 25, 2999-3005.
62. Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S. et al. (2001). The tripartite motif family identifies cell compartments. EMBO J. 20, 2140-2051.
63. Rockel, T. D., Stuhlmann, D. and von Mikeez, A. (2005). Proteasomes degrade proteins in focal subdomains of the human cell nucleus. J. Cell Sci. 118, 5231-5242.
64. Saitoh, N., Uchimura, Y., Tachibana, T., Sugahara, S., Saitoh, H. and Nakao, M. (2006). In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies. Exp. Cell Res. 312, 1418-1430.
65. Sanz, M. M., Proytcheva, M., Ellis, N. A., Holloman, W. K. and German, J. (2000). BLM, the Bloom's syndrome protein, varies during the cell cycle in its amount, distribution, and co-localization with other nuclear proteins. Cytogenet. Cell Genet. 91, 217-223.
66. Saxton, M. J. (2001). Anomalous subdiffusion in fluorescence photobleaching recovery: a Monte Carlo study. Biophys. J. 81, 2226-2240.
67. Schmiedeberg, L., Weisshart, K., Diekmann, S., Hoerste, G. M. and Hemmerich, P. (2004). High- and low-mobility populations of HP1 in heterochromatin and mammalian cells. Mol. Biol. Cell. 15, 2819-2833.
68. Seeler, J. S. and Dejean, A. (2001). SUMO: of branched proteins and nuclear bodies. Oncogene 20, 7243-7249.
69. Seeler, J. S., Marchio, A., Sitterlin, D., Transy, C. and Dejean, A. (1998). Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc. Natl. Acad. Sci. USA 95, 7316-7321.
70. Shen, T. H., Lin, H. K., Scaglioni, P. P., Yung, T. M. and Pandolfi, P. P. (2006). The mechanisms of PML-nuclear body formation. Mol. Cell. 24, 331-339.
71. Shiels, C., Islam, S. A., Vatcheva, R., Sasieni, P., Sternberg, M. J., Freemont, P. S. and Sheer, D. (2001). PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J. Cell Sci. 14, 3705-3716.
72. Song, J., Durrin, L. K., Wilkinson, T. A., Krontiris, T. G. and Chen, Y. (2004). Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. USA. 101, 14373-14378.
73. Sprague, B. L. and McNally, J. G. (2005). FRAP analysis of binding: proper and fitting. Trends Cell Biol. 15, 84-91.
74. Sternsdorf, T., Jensen, K. and Will, H. (1997). Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139, 1621-1634.
75. Sternsdorf, T., Jenseng, K., Reich, B., and Will, H. (1999). The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274, 12555-12566.
76. Sternsdorf, T., Gostissa, M., Sirma, H., Del Sal, G., Ruthard, M., Schmitz, M. L., Will, H. and Hofmann, T. G. (2005). PML nuclear bodies: Cellular function and disease association. In Visions of the Cell Nucleus (ed. P. Hemmerich and S. Diekmann). California: American Scientific Publishers.
77. Swaminathan, R., Hoang, C. P. and Verkman, A. S. (1997). Photobleaching recovery and anisotropy decay of green fluorescent protein GFP-S65T in solution and cells: cytoplasmic viscosity probed by green fluorescent protein translational and rotational diffusion. Biophys. J. 72, 1900-1907.
78. Wachsmuth, M. Waldeck. W. and Langowski, J. (2000). Anomalous diffusion of fluorescent probes inside living cell nuclei investigated by spatially-resolved fluorescence correlation spectroscopy. J. Mol. Biol. 298, 677-689.
79. Weidtkamp-Peters, S., Weisshart, K., Schmiedeberg, L. and Hemmerich, P. (2008). Fluorescence correlation spectroscopy to assess the mobility of nuclear proteins. Methods Mol. Biol. (in press).
80. Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A. and Dejean, A. (1994). Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76, 345-356.
81. Wiesmeijer, K., Molenaar, C., Bekeer, I. M., Tanke, H. J. and Dirks, R. W. (2002). Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not. J. Struct. Biol. 140, 180-188.
82. Wu, L. (2007). Role of the BLM helicase in replication fork management. DNA Repair 6, 936-944.
83. Xu, Z. X. Zou, W. X., Lin, P. and Chang K. S. (2005). A role for PML3 in centrosome duplication and genome stability. Mol. Cell. 17, 721-732
84. Zhong, S., Muller, S., Ronchetti S., Freemont, P. S., Dejean, A. and Pandolfi, P. P. (2000). Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752.